Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Martin Kammel"'
Autor:
Esmeralda Valiente, Samreen Falak, Andreas Kummrow, Martin Kammel, Victor M. Corman, Rainer Macdonald, Heinz Zeichhardt
Publikováno v:
BMC Research Notes, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Objective In routine clinical laboratories, severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is determined by reverse-transcription PCR (RT-PCR). In the COVID pandemic, a wide range of antigen detection tests were also in
Externí odkaz:
https://doaj.org/article/9a71ac76d7a949a4be638f7dd7428d29
Autor:
Laura Vierbaum, Nathalie Wojtalewicz, Hans-Peter Grunert, Anika Zimmermann, Annemarie Scholz, Sabine Goseberg, Patricia Kaiser, Ulf Duehring, Christian Drosten, Victor Corman, Daniela Niemeyer, Holger F. Rabenau, Martin Obermeier, Andreas Nitsche, Janine Michel, Andreas Puyskens, Jim F. Huggett, Denise M. O’Sullivan, Eloise Busby, Simon Cowen, Peter M. Vallone, Megan H. Cleveland, Samreen Falak, Andreas Kummrow, Ingo Schellenberg, Heinz Zeichhardt, Martin Kammel
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The COVID-19 pandemic illustrated the important role of diagnostic tests, including lateral flow tests (LFTs), in identifying patients and their contacts to slow the spread of infections. INSTAND performed external quality assessments (EQA)
Externí odkaz:
https://doaj.org/article/382f64418a09458f986183c39daac0a4
Autor:
Laura Vierbaum, Nathalie Wojtalewicz, Anne Kaufmann, Sabine Goseberg, Patricia Kaiser, Hans-Peter Grunert, Ulf Dühring, Anika Zimmermann, Annemarie Scholz, Janine Michel, Andreas Nitsche, Holger F Rabenau, Martin Obermeier, Ingo Schellenberg, Heinz Zeichhardt, Martin Kammel
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0285203 (2023)
BackgroundIn May 2022, the monkeypox virus (MPXV) spread into non-endemic countries and the global community was quick to test the lessons learned from the SARS-CoV-2 pandemic. Due to its symptomatic resemblance to other diseases, like the non-pox vi
Externí odkaz:
https://doaj.org/article/1f0c19c2bfff453aa00415ab790ec252
Autor:
William Jonathan Windsor, Yannik Roell, Heidi Tucker, Chi-An Cheng, Sara Suliman, Laura J. Peek, Gary A. Pestano, William T. Lee, Heinz Zeichhardt, Molly M. Lamb, Martin Kammel, Hui Wang, Ross Kedl, Cody Rester, Thomas E. Morrison, Bennet J. Davenport, Kyle Carson, Jennifer Yates, Kelly Howard, Karen Kulas, David R. Walt, Aner Dafni, Daniel Taylor, May Chu
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
BackgroundThere is an urgent need for harmonization between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology platforms and assays prior to defining appropriate correlates of protection and as well inform the development of new ra
Externí odkaz:
https://doaj.org/article/3ec7571617af45718e06f6040746fb43
Autor:
Laura Vierbaum, Nathalie Wojtalewicz, Hans-Peter Grunert, Vanessa Lindig, Ulf Duehring, Christian Drosten, Victor Corman, Daniela Niemeyer, Sandra Ciesek, Holger F Rabenau, Annemarie Berger, Martin Obermeier, Andreas Nitsche, Janine Michel, Martin Mielke, Jim Huggett, Denise O'Sullivan, Eloise Busby, Simon Cowen, Peter M Vallone, Megan H Cleveland, Samreen Falak, Andreas Kummrow, Thomas Keller, Ingo Schellenberg, Heinz Zeichhardt, Martin Kammel
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262656 (2022)
SARS-CoV-2, the cause of COVID-19, requires reliable diagnostic methods to track the circulation of this virus. Following the development of RT-qPCR methods to meet this diagnostic need in January 2020, it became clear from interlaboratory studies th
Externí odkaz:
https://doaj.org/article/3de1ec4f9c8e40dcac6912d35effd9bf
Autor:
Niko Kohmer, Tuna Toptan, Christiane Pallas, Onur Karaca, Annika Pfeiffer, Sandra Westhaus, Marek Widera, Annemarie Berger, Sebastian Hoehl, Martin Kammel, Sandra Ciesek, Holger F. Rabenau
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 2, p 328 (2021)
Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction (rRT-PCR)-based testing have been exhausted. In order to meet the deman
Externí odkaz:
https://doaj.org/article/3a5cb162ff384ddba1c828af0825c18e
Autor:
Tim Mercer, Neil Almond, Michael A. Crone, Patrick S. G. Chain, Alina Deshpande, Deepa Eveleigh, Paul Freemont, Sebastien Fuchs, Russell Garlick, Jim Huggett, Martin Kammel, Po-E Li, Mojca Milavec, Elizabeth M. Marlowe, Denise M. O’Sullivan, Mark Page, Gary A. Pestano, Sara Suliman, Birgitte Simen, John J. Sninsky, Lynne Sopchak, Cristina M. Tato, Peter M. Vallone, Jo Vandesompele, Thomas J. White, Heinz Zeichhardt, Marc Salit
Publikováno v:
Nature Biotechnology. 40:1563-1568
Autor:
Christoph Buchta, Heinz Zeichhardt, Stephan W Aberle, Jeremy V Camp, Irene Görzer, Lukas Weseslindtner, Elisabeth Puchhammer-Stöckl, Wolfgang Huf, Bernhard Benka, Franz Allerberger, Martin Mielke, Andrea Griesmacher, Mathias M Müller, Ingo Schellenberg, Martin Kammel
Publikováno v:
The Lancet Microbe.
Autor:
Martin Kammel, Samreen Falak, Jim F. Huggett, Annabell Plauth, Denise M. O'Sullivan, Rainer Macdonald, Mojca Milavec, Heinz Zeichhardt, Andreas Kummrow, Eloise J. Busby, Hans-Peter Grunert
Publikováno v:
Methods. 201:34-40
Viral load monitoring in human immunodeficiency virus type 1 (HIV-1) infection is often performed using reverse transcription quantitative PCR (RT-qPCR) to observe response to treatment and identify the development of resistance. Traceability is achi
Autor:
Denise M. O'Sullivan, Ki Ho Hong, Kathryn A. Harris, Jacob Moran-Gilad, Daniel Evans, Jiwon In, Heinz Zeichhardt, Martin Kammel, Julian Braybrook, Suzie Hingley-Wilson, Ulf Dühring, Jo Vandesompele, Nathaniel Storey, Jim F. Huggett, Carole A. Foy, Simon Cowen, Graham R. Stewart, Young-Kyung Bae, Jasper Verwilt, Hans-Peter Grunert
Publikováno v:
CLINICAL CHEMISTRY
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA quantities, measured by reverse transcription quantitative PCR (RT-qPCR), have been proposed to stratify clinical risk or determine analytical performance targets. We investi